BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6421101)

  • 1. On the mechanism of platelet activation during hemostasis and thrombosis and on the effects of platelet inhibiting drugs.
    Breddin K; Bender N; Kirchmaier CM
    Adv Exp Med Biol; 1984; 164():145-54. PubMed ID: 6421101
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aspirin resistance: position paper of the working group on aspirin resistance of the international society on thrombosis and haemostasis].
    Boskholov BP
    Kardiologiia; 2005; 45(7):75-6. PubMed ID: 16091668
    [No Abstract]   [Full Text] [Related]  

  • 3. [Primary thrombocyte reactions in hemostasis and thrombogenesis and the possibilities of influencing them by drugs].
    Breddin K
    Z Gesamte Inn Med; 1984 May; 39(10):234-41. PubMed ID: 6380127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet function and pharmacologic inhibition.
    Chaer RA; Graham JA; Mureebe L
    Vasc Endovascular Surg; 2006; 40(4):261-7. PubMed ID: 16959718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis.
    Schafer AI
    J Clin Pharmacol; 1995 Mar; 35(3):209-19. PubMed ID: 7608308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet agents: rationale and results.
    Kelton JG
    Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
    [No Abstract]   [Full Text] [Related]  

  • 7. Impaired responsiveness to clopidogrel and aspirin in patients with recurrent stent thrombosis following percutaneous intervention for peripheral artery disease.
    Mazur P; Frołow M; Niżankowski R; Sadowski J; Undas A
    Platelets; 2013; 24(2):151-5. PubMed ID: 22497730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 24-hour antiplatelet effect of aspirin in patients with previous definite stent thrombosis.
    Würtz M; Hvas AM; Jensen LO; Kaltoft AK; Tilsted HH; Kristensen SD; Grove EL
    Int J Cardiol; 2014 Aug; 175(2):274-9. PubMed ID: 24861258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Platelets and arterial thrombosis].
    Cazenave JP; Gachet C; Lanza F; Wiesel ML
    Bull Acad Natl Med; 2003; 187(1):35-44; discussion 45-6. PubMed ID: 14556452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood platelets and the inflammatory process.
    Silver MJ; Smith JB; Ingerman CM
    Agents Actions; 1974 Oct; 4(4):233-40. PubMed ID: 4447066
    [No Abstract]   [Full Text] [Related]  

  • 11. Interruption of thrombosis and hemostasis by anti-platelet agents.
    Shebuski RJ
    Toxicol Pathol; 1993; 21(2):180-9. PubMed ID: 8210940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of newer platelet function tests ot define abnormalities of hemostasis and thrombosis.
    Hoak JC; Wu KK; Fry GL
    Ser Haematol; 1975; 8(3):81-8. PubMed ID: 824740
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspirin dosage and antithrombotic effect.
    Clagett GP; Russo M; Hufnagel H; Collins GJ; Rich NM
    Surg Forum; 1979; 30():199-201. PubMed ID: 538593
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelets in vascular disease.
    Reinhart WH
    Clin Hemorheol Microcirc; 2013; 53(1-2):71-9. PubMed ID: 22954635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Status and trends in the field of inhibitors of thrombocyte function].
    Glusa E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):575-9. PubMed ID: 6083929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of action of currently used antiplatelet drugs.
    de Gaetano G; Bertele' V; Cerletti C
    Agents Actions Suppl; 1986; 20():191-201. PubMed ID: 3101442
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of platelet functional changes and effects of anti-platelet agents on in vivo hemostasis under different gravity conditions.
    Li S; Shi Q; Liu G; Zhang W; Wang Z; Wang Y; Dai K
    J Appl Physiol (1985); 2010 May; 108(5):1241-9. PubMed ID: 20133435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets and thromboembolism.
    Aledort LM
    Semin Thromb Hemost; 1976 Jan; 2(3):136-45. PubMed ID: 798273
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence for 20 mg aspirin (ASA) as being optimal.
    Sinzinger H; Virgolini I; Eyb R; Fitscha P; Kaliman J
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():303-6. PubMed ID: 2526489
    [No Abstract]   [Full Text] [Related]  

  • 20. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.
    Kobzar G; Mardla V; Samel N
    Platelets; 2011; 22(5):338-44. PubMed ID: 21557683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.